Invention Publication
- Patent Title: PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES
-
Application No.: US18492612Application Date: 2023-10-23
-
Publication No.: US20240150405A1Publication Date: 2024-05-09
- Inventor: Chengzao SUN , Brian Troy FREDERICK , Sandeep SOMANI , Gregory Thomas BOURNE , Raymond PATCH , Ashok BHANDARI , Raffaele INGENITO , Roberto COSTANTE , Danila BRANCA , Elisabetta BIANCHI
- Applicant: Janssen Biotech, Inc. , Protagonist Therapeutics, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.,Protagonist Therapeutics, Inc.
- Current Assignee: Janssen Biotech, Inc.,Protagonist Therapeutics, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K7/64
- IPC: C07K7/64
Abstract:
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Information query
